-
Clinical and Economic Impact of Early Treatment in Relapsing Remitting Multiple Sclerosis With High-Efficacy Disease-Modifying Therapy in Mexico
Sep 9, 2025, 16:22 PM -
Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic
Sep 9, 2025, 16:22 PM -
Triangulation Method to Detect Meaningful Deterioration in Patient's Autonomy Using the New Multiple Sclerosis Autonomy Scale (MSAS) Questionnaire
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of an AI-Based Smartphone App for the Early Detection of Skin Cancer: A Decision Tree Analysis
Sep 9, 2025, 16:22 PM -
Graphical Evidence Frameworks to Visualize the Holistic Value of Healthcare Interventions
Sep 9, 2025, 16:22 PM -
A Decade of Change in Turkish Healthcare Utilization: Hospital Admission Trends 2015-2024
Sep 9, 2025, 16:22 PM -
NCFBE Hospitalizations Costs Across Different Healthcare Systems: Insights From England and France in 2022 Using PMSI and HES Databases
Sep 9, 2025, 16:22 PM -
Content Validation of a Modified PozQoL for Assessing HIV Therapies
Sep 9, 2025, 16:22 PM -
Reframing Pharmaceutical Pricing: Implications of the 2025 SVR Report for Germany’s Pricing Logic and International Spillovers
Sep 9, 2025, 16:22 PM -
Forecasting the Rise in Direct and Indirect Costs for Lung Cancer on the Example of Poland
Sep 9, 2025, 16:22 PM -
Physicians’ Knowledge, Attitude, and Practice Regarding Medical Liability: A Study in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Barriers and Policy Solutions in Off-Patent Drug Repurposing: A Full-Life-Cycle Perspective
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
Costs of Breast Cancer Surgical Care in Newly Diagnosed Patients in 2015 and 2019: A French Nationwide Claims Database Study
Sep 9, 2025, 16:22 PM -
Improving Access to German Health Claims Data Through Synthetic Data Generation: Findings and Achievements of a Holistic Evaluation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM -
A Comprehensive Approach Including Mailed FITs and Nurse Navigation for Colorectal Cancer Screening
Sep 9, 2025, 16:22 PM -
Impact of Temporarily Implanted Nitinol Device in the Treatment of Urinary Symptoms in Patients With Benign Prostatic Obstruction in Spain
Sep 9, 2025, 16:22 PM -
IMF: The Innovative Medicines Fund or the Interim Medicines Fund?
Sep 9, 2025, 16:22 PM
